# Foghorn Therapeutics Inc. (FHTX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Foghorn Therapeutics Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/FHTX/mda/fy2025/): filed 2026-03-11; accession 0001628280-26-016814 (https://www.sec.gov/Archives/edgar/data/1822462/000162828026016814/fhtx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/FHTX/mda/fy2024/): filed 2025-03-06; accession 0001628280-25-010933 (https://www.sec.gov/Archives/edgar/data/1822462/000162828025010933/fhtx-20241231.htm)
- [FY 2023 MD&A](/company/FHTX/mda/fy2023/): filed 2024-03-07; accession 0001628280-24-009539 (https://www.sec.gov/Archives/edgar/data/1822462/000162828024009539/fhtx-20231231.htm)
- [FY 2022 MD&A](/company/FHTX/mda/fy2022/): filed 2023-03-09; accession 0001628280-23-007297 (https://www.sec.gov/Archives/edgar/data/1822462/000162828023007297/fhtx-20221231.htm)
- [FY 2021 MD&A](/company/FHTX/mda/fy2021/): filed 2022-03-10; accession 0001628280-22-005753 (https://www.sec.gov/Archives/edgar/data/1822462/000162828022005753/fhtx-20211231.htm)

Back to /company/FHTX/